Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Clinical PET/CT imaging: promises and misconceptions.

J Czernin1, M A Auerbach

  • 1Department of Molecular and Medical Pharmacology, Ahmanson Biological Imaging Center/Nuclear Medicine, David Geffen School of Medicine at UCLA, Los Angeles 90095-6948, USA. jczernin@mednet.ucla.edu

Nuklearmedizin. Nuclear Medicine
|January 7, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Gout and Its Treatment.

Buffalo medical journal·2023
Same author

Summer Diarrheas of Children and Their Treatment.

Buffalo medical journal·2023
Same author

Summer Diarrheas of Children and Their Treatment.

Atlanta journal-record of medicine·2022
Same author

COVID-19 pandemic: guidance for nuclear medicine departments.

European journal of nuclear medicine and molecular imaging·2020
Same author

Advancing Biomarker Development Through Convergent Engagement: Summary Report of the 2nd International Danube Symposium on Biomarker Development, Molecular Imaging and Applied Diagnostics; March 14-16, 2018; Vienna, Austria.

Molecular imaging and biology·2019
Same author

SU-E-I-82: Image Signal-To-Noise Equalization in Whole Body PET Using Variable Acquisition Times.

Medical physics·2017
Same journal

On the utility of ChatGPT in conducting a literature review on deep learning for dopamine transporter SPECT with [¹²³I]ioflupane.

Nuklearmedizin. Nuclear medicine·2026
Same journal

McCune-Albright Syndrome with Extensive Fibrous Dysplasia Evaluated by 18F-FDG PET/CT and Whole-body Bone Scintigraphy: A Case Report.

Nuklearmedizin. Nuclear medicine·2026
Same journal

False-Positive Rib Lesion on Bone Scintigraphy and 68Ga-PSMA PET/CT: Fibrous Dysplasia Mimicking Metastasis.

Nuklearmedizin. Nuclear medicine·2026
Same journal

PSMA-exprimierende Nebennierenläsion beim Prostatakarzinom: Phäochromozytom statt Metastase.

Nuklearmedizin. Nuclear medicine·2026
Same journal

A translational journey in Germany: From literature to local implementation of [89Zr]Zr-DFO-trastuzumab.

Nuklearmedizin. Nuclear medicine·2026
Same journal

[68Ga]Ga-FAPI-04 PET/CT Delineates Peritoneal Carcinomatosis in Invasive Lobular Breast Cancer with Limited FDG Avidity.

Nuklearmedizin. Nuclear medicine·2026
See all related articles

Positron Emission Tomography/Computed Tomography (PET/CT) is crucial for cancer staging and restaging. Future success relies on molecular imaging probes for personalized cancer therapy, not just advanced equipment.

Area of Science:

  • Oncology
  • Medical Imaging
  • Molecular Imaging

Background:

  • Positron Emission Tomography/Computed Tomography (PET/CT) is a vital tool in modern oncology.
  • PET/CT offers superior accuracy in cancer staging and restaging compared to PET or CT alone.

Purpose of the Study:

  • To advocate for a more tailored equipment design in PET/CT systems.
  • To emphasize the shift towards molecular imaging advancements for personalized cancer care.

Main Methods:

  • Review of current PET/CT applications in oncology.
  • Analysis of the balance between technological equipment advancements and molecular imaging innovations.

Main Results:

  • Current PET/CT technology provides high accuracy in cancer staging and restaging.

Related Experiment Videos

  • The optimal use of PET/CT requires equipment design aligned with specific clinical needs and patient groups.

    • Conclusions:

    • The future of molecular PET/CT in oncology depends on targeted imaging probes for individualized cancer therapy.
    • Advancements in molecular imaging are more critical than further technological upgrades to imaging equipment for continued success.